Sticker shock isn’t slowing Americans’ fervor for weight-loss drugs as a new analysis finds the drugs can cost five times as much — or more — in the US than they do elsewhere in the world.
A one-month supply of Ozempic,
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
